Company to hold R&D webcast today at 4:00 pm ET to review ongoing clinical programs in Alzheimer's disease and Parkinson's disease
Updated Webcast link and dial-in information are provided below
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Company to hold R&D webcast today at 4:00 pm ET to review ongoing clinical programs in Alzheimer's disease and Parkinson's disease
Updated Webcast link and dial-in information are provided below
Read more at prnewswire.comSymbol | Last | Chg | %Chg |
---|---|---|---|
ANVS | 2.96 | +0.16 | +5.71% |
Annovis Bio Inc |